These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5786507)

  • 41. Effect of immunosuppression and splenectomy in transplantation sarcomas in mice.
    Nigam SK; Bhatt HV
    Panminerva Med; 1996 Dec; 38(4):217-22. PubMed ID: 9063029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the murine plasma-cell neoplasm, X5563. II. Accelerated immunologic reactivity to transplanted tumor induced in C3H mice by transferred immune rabbit cells.
    Gordon BL II; Fong J
    Ann Allergy; 1967 Sep; 25(9):471-82. PubMed ID: 6053557
    [No Abstract]   [Full Text] [Related]  

  • 43. The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice.
    Vyakarnam A; Lachmann PJ; Sikora K
    Immunology; 1981 Feb; 42(2):337-48. PubMed ID: 6161889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A model system for examining the action of anti-cancer agents at the cellular level in vivo.
    Bruce WR
    Natl Cancer Inst Monogr; 1967 Feb; 24():249-56. PubMed ID: 6021079
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
    Shanker A; Singh SM
    Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Murine splenocyte migration inhibition assay. II. Characterization of splenic suppressor cells in mice bearing P388/ADR tumor.
    Nori M; Chitnis MP; Gothoskar BP
    Neoplasma; 1983; 30(4):421-6. PubMed ID: 6225029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HPV16-associated tumours: therapy of surgical minimal residual disease with dendritic cell-based vaccines.
    Reinis M; Indrová M; Mendoza L; Mikysková R; Bieblová J; Bubeník J; Símová J
    Int J Oncol; 2004 Oct; 25(4):1165-70. PubMed ID: 15375569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solid intraperitoneal Landschütz tumour in mice: implications in cancer chemotherapy and immunology studies.
    Hod I; Zimber A; Gidoni D; Schonfeld S
    Lab Anim; 1975 Oct; 9(4):319-27. PubMed ID: 1207037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests.
    Rivosecchi Merletti P; Bianchi R; Nardelli B; Iorio AM; Campanile F; Migliorati G; Bonmassar E
    Int J Tissue React; 1983; 5(1):19-27. PubMed ID: 6862787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Criteria associated with destruction of leukemia and solid tumor cells in animals.
    Skipper HE
    Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
    [No Abstract]   [Full Text] [Related]  

  • 53. [Role of immunologic activity of host in radiotherapy].
    Tsuchiya T
    Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of cyclophosphamide on spleen cell suppressor activity and tumour growth in mice.
    Larsen FS; Spärck JV
    Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):323-33. PubMed ID: 6229132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
    Mokyr MB; Dray S
    Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of IgM, IgA and IgG secreting cells in the tissues of normal and tumour-bearing mice.
    Howie S; McBride WH; James K
    Immunology; 1982 May; 46(1):43-8. PubMed ID: 7042550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class I and Fas expressions.
    Tzai TS; Shiau AL; Liu LL; Wu CL
    Anticancer Res; 2000; 20(3A):1557-62. PubMed ID: 10928070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Inhibition of the growth of a syngeneic weakly immunogenic tumor in mice resulting from exposures affecting T lymphocyte activity].
    Babadzhanov AS; Buntsevich AM
    Biull Eksp Biol Med; 1983 Apr; 95(4):69-71. PubMed ID: 6338967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F; Nomoto K; Taniguchi K; Kubo C
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on NZB/BL mice II. Incidence and type of tumours, preliminary observations on the evolution of transplanted tumours and its relationship with age and body weight (author's transl)].
    Sánchez Fayos J; DE Bonaparte YP; Celeste F; d'ELIA IS; Klein S
    Sangre (Barc); 1976; 21(2):311-22. PubMed ID: 948780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.